{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T07:17:41Z","timestamp":1782544661554,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsradet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jinf.2021.05.031","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T19:58:37Z","timestamp":1622318317000},"page":"190-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Characterization of Streptococcus pneumoniae detected in clinical respiratory tract samples in southern Sweden 2 to 4 years after introduction of PCV13"],"prefix":"10.1016","volume":"83","author":[{"given":"Fabian","family":"Udd\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"R\u00fcnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Christian","family":"Slotved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Fuursted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Ahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Riesbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jinf.2021.05.031_bib0001","first-page":"1191","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study","volume":"18","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2021.05.031_bib0002","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/cid\/cix685","article-title":"Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations","volume":"65","author":"Naucler","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2021.05.031_bib0003","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1183\/13993003.01451-2015","article-title":"Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden","volume":"47","author":"Galanis","year":"2016","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.jinf.2021.05.031_bib0004","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/apa.14824","article-title":"Sustained reductions of invasive infectious disease following general infant Haemophilus influenzae type b and pneumococcal vaccination in a Swedish Arctic region","volume":"108","author":"Johansson Kostenniemi","year":"2019","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.jinf.2021.05.031_bib0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/joim.12956","article-title":"The changing epidemiology of community-acquired pneumonia: nationwide register-based study in Sweden","volume":"286","author":"Naucler","year":"2019","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.jinf.2021.05.031_bib0006","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/INF.0000000000001654","article-title":"Trends in otitis media incidence after conjugate pneumococcal vaccination: a national observational study","volume":"36","author":"Gisselsson-Solen","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.jinf.2021.05.031_bib0007","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thoraxjnl-2018-211767","article-title":"Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination","volume":"74","author":"Hanquet","year":"2019","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jinf.2021.05.031_bib0008","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12879-016-1750-5","article-title":"Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county","volume":"16","author":"Littorin","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2021.05.031_bib0009","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/14760584.2017.1362339","article-title":"Streptococcus pneumoniae serotype 19A: worldwide epidemiology","volume":"16","author":"Isturiz","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.jinf.2021.05.031_bib0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40249-018-0422-7","article-title":"Aerobic bacteria associated with chronic suppurative otitis media in Angola","volume":"7","author":"Udd\u00e9n","year":"2018","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.jinf.2021.05.031_bib0011","series-title":"Essential medical statistics","author":"Kirkwood","year":"2003"},{"key":"10.1016\/j.jinf.2021.05.031_bib0012","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Warning against the use of gradient tests for benzylpenicillin MIC in Streptococcus pneumoniae [Internet]. 2019 Nov 21 [cited 2020 Nov 30]. Available from: https:\/\/eucast.org\/ast_of_bacteria\/warnings\/."},{"key":"10.1016\/j.jinf.2021.05.031_bib0013","article-title":"Decreased prevalence of Moraxella catarrhalis in addition to Streptococcus pneumoniae in children with upper respiratory tract infection after introduction of conjugated pneumococcal vaccine - A retrospective cohort study","author":"Littorin","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"38","key":"10.1016\/j.jinf.2021.05.031_bib0014","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2016.07.031","article-title":"Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden","volume":"34","author":"Lindstrand","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jinf.2021.05.031_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01766-18","article-title":"Vaccination of Icelandic children with the 10-valent pneumococcal vaccine leads to a significant herd effect among Adults in Iceland","volume":"57","author":"Quirk","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.jinf.2021.05.031_bib0016","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1128\/AAC.00182-15","article-title":"Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States in 2009 to 2012","volume":"59","author":"Mendes","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.jinf.2021.05.031_bib0017","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"Dagan","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2021.05.031_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220453","article-title":"Limited indirect effects of an infant pneumococcal vaccination program in an aging population","volume":"14","author":"van der Linden","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2021.05.031_bib0019","article-title":"Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study","author":"Desmet","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2021.05.031_bib0020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jinf.2018.06.004","article-title":"The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: a systematic review and meta-analysis","volume":"77","author":"Balsells","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2021.05.031_bib0021","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12879-015-0941-9","article-title":"Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era","volume":"15","author":"van der Linden","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2021.05.031_bib0022","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1128\/AAC.03344-14","article-title":"Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States","volume":"58","author":"Richter","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"21","key":"10.1016\/j.jinf.2021.05.031_bib0023","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2017.04.019","article-title":"Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: the emergence of multidrug resistant serotype 6C","volume":"35","author":"Neves","year":"2017","journal-title":"Vaccine"},{"issue":"suppl_7","key":"10.1016\/j.jinf.2021.05.031_bib0024","doi-asserted-by":"crossref","first-page":"vii12","DOI":"10.1093\/jac\/dky158","article-title":"Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15","volume":"73","author":"Adam","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"52","key":"10.1016\/j.jinf.2021.05.031_bib0025","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1016\/j.vaccine.2013.10.032","article-title":"Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway","volume":"31","author":"Steens","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2021.05.031_bib0026","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2334-13-70","article-title":"Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children","volume":"13","author":"van der Linden","year":"2013","journal-title":"BMC Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321002747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321002747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:33:06Z","timestamp":1759008786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445321002747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0163445321002747"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2021.05.031","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of Streptococcus pneumoniae detected in clinical respiratory tract samples in southern Sweden 2 to 4 years after introduction of PCV13","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2021.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}